Serum thyrotrophin and response to thyrotrophin-releasing hormone in patients who are euthyroid after radioiodine treatment for hyperthyroidism.
D000236:Adenoma / Q000628:therapy; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006042:Goiter / Q000628:therapy; D006044:Goiter, Nodular / Q000628:therapy; D006801:Humans; D006980:Hyperthyroidism / Q000532:radiotherapy*; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011829:Radiation Dosage; D011830:Radiation Effects; D013954:Thyroglobulin; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000528:radiation effects; D013964:Thyroid Neoplasms / Q000628:therapy; D013972:Thyrotropin / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone; D013974:Thyroxine / Q000097:blood; D013997:Time Factors; D014284:Triiodothyronine / Q000097:blood
D000906:Antibodies; D007457:Iodine Radioisotopes; D014284:Triiodothyronine; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D013954:Thyroglobulin; D002784:Cholesterol; D013974:Thyroxine